Gastrointestinal inflammation affects millions of people and animals worldwide but there is a lack of satisfactory treatments.
Gastrointestinal inflammation affects millions of people and animals worldwide but there is a lack of satisfactory treatments.
FX856: Your Iron loving probiotic for better gut health
Probiotic
Our lead product is a rationally selected bacterial strain (FX856) with anti-inflammatory properties demonstrated in standard gastrointestinal disease models. FX856 is functional during active disease, has an excellent safety profile, and a scalable manufacturing process. FX856 benefits from regulatory exemptions (GRAS in USA, QPS in Europe) meaning it has a shortened development pathway; independent regulatory advice indicates no requirement for preclinical safety testing or healthy volunteer trials for development as a therapeutic.
Food Supplement
Our food supplement is classified as Generally Regarded as Safe (GRAS) by the FDA and therefore does not require additional safety and tolerance studies allowing immediate access to the food supplement market.
FX856 is manufactured through an identified contract manufacturer and will be supplied in blister packs of 30 capsules (one month's supply).
Competitive Advantage
Our products have three unique key attributes:
• Capable of surviving and thriving in the actively inflamed gut
• Demonstrated mucosal healing
• Excellent safety profile
FX856 is well placed to be used as a cost-effective single or adjunctive early therapy in efforts to initiate or prolong remission.
Our products’ brochures dive more into our solutions and our FX856 co-development opportunities.
Join our newsletter to learn more about our solutions
FERRYX LTD
Future Space,
UWE North Gate,
Filton Road,
Bristol,
BS34 8RB.
Follow Us
